Azienda Ulss 6 Euganea
6
1
1
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia
Role: collaborator
Factors Influencing Home Nursing Care Service
Role: collaborator
Educational Interventions in Venous Leg Ulcer
Role: collaborator
"Serratus Anterior Plane Block" Versus "Serratus Posterior Superior Plane Intercostal Plane Block" for Patients Undergoing Breast Surgery
Role: collaborator
Conservative Management of CIN2 Lesions and Biomarkers Evaluation
Role: collaborator
A Protocol to Streamline Dental Care in Autistic Children
Role: collaborator
All 6 trials loaded